New Delhi, India – October 17, 2024 – Asprius Lifesciences, a leading name in the pharmaceutical industry, is proud to announce the launch of its cutting-edge Tablets for Hypertension and Diabetes Treatment. This innovative medication is designed to provide effective and reliable solutions for managing two of the most prevalent chronic conditions worldwide—hypertension and diabetes.

With millions of people affected by these lifestyle diseases, the launch of these specialized tablets underscores Asprius Lifesciences' commitment to improving public health through advanced medical treatments.

Addressing a Global Health Crisis
Hypertension (high blood pressure) and diabetes are two interconnected conditions that often occur together, increasing the risk of serious complications such as heart disease, stroke, kidney failure, and vision problems. According to the World Health Organization (WHO), over 1.13 billion people globally suffer from hypertension, while diabetes affects more than 537 million adults, with numbers expected to rise.

Asprius Lifesciences’ new tablets are formulated to help patients manage both conditions simultaneously, offering a dual benefit that helps control blood pressure and regulate blood sugar levels, thereby reducing the risk of long-term complications.

Key Features of the Tablets
Comprehensive Treatment: The tablets target both hypertension and diabetes, reducing the need for multiple medications and streamlining treatment for patients.
Advanced Formulation: Using the latest pharmaceutical research, Asprius Lifesciences has developed a unique formula that helps maintain optimal blood pressure levels while controlling blood sugar.
Proven Efficacy: Clinical trials have shown significant improvement in blood pressure and glucose levels in patients using the tablets, offering a promising option for long-term management of these conditions.
Minimal Side Effects: The new formulation is designed to minimize common side effects associated with hypertension and diabetes medications, ensuring safer long-term use for patients.
Convenience: Available in an easy-to-swallow tablet form, the medication is ideal for patients seeking convenience and efficacy in managing both conditions.
Expert Insights
Speaking about the launch, Dr. Priya Kapoor, Chief Medical Officer at Asprius Lifesciences, said, "Our aim with these new tablets is to provide a more efficient and patient-friendly approach to treating hypertension and diabetes. These are two of the most pressing health challenges globally, and managing both conditions with a single, well-formulated tablet can improve the quality of life for millions of patients."

Dr. Kapoor added, "The pharmaceutical industry must innovate continually to meet the growing demands of chronic disease management. This launch is a step forward in ensuring patients have access to the best possible treatment options."

The Science Behind the Tablets
The innovation behind Asprius Lifesciences' Tablets for Hypertension and Diabetes Treatment lies in its dual-action formula. The tablets combine:

Angiotensin II Receptor Blockers (ARBs): A class of drugs proven to lower blood pressure by relaxing blood vessels.
Biguanides: A widely-used diabetes treatment that helps regulate blood sugar levels by improving the body's insulin sensitivity.
By combining these two powerful ingredients, Asprius Lifesciences has created a medication that can address both conditions without compromising efficacy or safety.

Commitment to Patient Care
Asprius Lifesciences has a long-standing commitment to providing affordable, high-quality medications that meet the evolving needs of patients. The company is known for its focus on research and innovation, constantly pushing the boundaries of healthcare solutions.

Rajesh Mehra, CEO of Asprius Lifesciences, said, "This product launch marks another milestone in our journey to provide life-saving treatments for chronic conditions like hypertension and diabetes. Our mission is to ensure that patients can manage their health effectively while maintaining a good quality of life."

Availability and Distribution
The Tablets for Hypertension and Diabetes Treatment will be available in pharmacies and hospitals across India from November 2024, with plans to expand availability to international markets in the coming year. The medication will be priced competitively to ensure accessibility for patients from all walks of life.

Healthcare providers, hospitals, and pharmacies interested in stocking the tablets can contact Asprius Lifesciences directly for more information on distribution.

About Asprius Lifesciences
Asprius Lifesciences is a leading pharmaceutical company dedicated to producing high-quality, affordable healthcare solutions. With a strong focus on research and development, Asprius Lifesciences offers a wide range of medicines for chronic and acute conditions, including cardiovascular diseases, diabetes, respiratory ailments, and more. The company is committed to improving public health through innovation and strives to make advanced healthcare accessible to all.

For more information about the new Tablets for Hypertension and Diabetes Treatment or other products by Asprius Lifesciences, please visit https://asprius.in/ or contact the press team at [email protected].

Contact us 

7, Om Complex, Near Swastik Cross Roads, CG Road, Ahmedabad-380009. Gujarat, India. 

Email: [email protected], [email protected] 

Call: +91 98795 33315, +91 79 4003 3144 

Facebook: https://www.facebook.com/asprius.in/ 

Twitter: https://twitter.com/aspriuslife 

Linkedin: https://www.linkedin.com/in/asprius-lifesciences-772a15143/ 

Website: https://asprius.in/discover-benefit-of-tablets-for-hypertension-and-diabetes-treatment/